199 related articles for article (PubMed ID: 31625581)
1. Aliskiren improves renal morphophysiology and inflammation in Wistar rats with 2K1C renovascular hypertension.
Pereira PG; Rabelo K; da Silva JFR; Ciambarella BT; Argento JGC; Nascimento ALR; Vieira AB; de Carvalho JJ
Histol Histopathol; 2020 Jun; 35(6):609-621. PubMed ID: 31625581
[TBL] [Abstract][Full Text] [Related]
2. Antihypertensive Effects of
Hong MH; Jin XJ; Yoon JJ; Lee YJ; Oh HC; Lee HS; Kim HY; Kang DG
Nutrients; 2020 Oct; 12(11):. PubMed ID: 33138042
[No Abstract] [Full Text] [Related]
3. Aliskiren Reduces the Adrenal Zona Glomerulosa Apoptosis and Autophagy in Wistar Rats with 2K1C Hypertension.
de Matos VS; do Nascimento ALR; Pereira PG; Rabelo K; Andrade CBV; Moraes ACN; Salata C; Araújo VHVO; Ciambarella BT; Bonfim Vieira A; Alves LL; da Silva JFR; de Carvalho JJ
Int J Hypertens; 2020; 2020():7684849. PubMed ID: 33145109
[TBL] [Abstract][Full Text] [Related]
4. Combined Aliskiren and L-arginine treatment reverses renovascular hypertension in an animal model.
Tiradentes RV; Santuzzi CH; Claudio ER; Mengal V; Silva NF; Neto HA; Bissoli NS; Abreu GR; Gouvea SA
Hypertens Res; 2015 Jul; 38(7):471-7. PubMed ID: 25740291
[TBL] [Abstract][Full Text] [Related]
5. Direct renin inhibition is not enough to prevent reactive oxygen species generation and vascular dysfunction in renovascular hypertension.
Martins-Oliveira A; Guimaraes DA; Ceron CS; Rizzi E; Oliveira DMM; Tirapelli CR; Casarini DE; Fernandes FB; Pinheiro LC; Tanus-Santos JE
Eur J Pharmacol; 2018 Feb; 821():97-104. PubMed ID: 29331564
[TBL] [Abstract][Full Text] [Related]
6. Greater reductions in plasma aldosterone with aliskiren in hypertensive patients with higher soluble (Pro)renin receptor level.
Bokuda K; Morimoto S; Seki Y; Yatabe M; Watanabe D; Yatabe J; Ando T; Shimizu S; Itoh H; Ichihara A
Hypertens Res; 2018 Jun; 41(6):435-443. PubMed ID: 29618841
[TBL] [Abstract][Full Text] [Related]
7. Aliskiren inhibits experimental venous thrombosis in two-kidney one- clip hypertensive rats.
Hermanowicz JM; Hermanowicz A; Buczko P; Leszczynska A; Tankiewicz-Kwedlo A; Mogielnicki A; Buczko W
Thromb Res; 2013 Jan; 131(1):e39-44. PubMed ID: 23174623
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the renin angiotensin aldosterone system: focus on aliskiren.
Rao MS
J Assoc Physicians India; 2010 Feb; 58():102-8. PubMed ID: 20653151
[TBL] [Abstract][Full Text] [Related]
9. Aliskiren and valsartan in combination is a promising therapy for hypertensive renal injury in rats.
Abdel Kawy HS
Clin Exp Hypertens; 2018; 40(6):560-568. PubMed ID: 29172824
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic evaluation of rutin in two-kidney one-clip model of renovascular hypertension in rat.
Kaur S; Muthuraman A
Life Sci; 2016 Apr; 150():89-94. PubMed ID: 26920631
[TBL] [Abstract][Full Text] [Related]
11. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
Horký K
Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
[TBL] [Abstract][Full Text] [Related]
12. Renal sympathetic denervation attenuates hypertension and vascular remodeling in renovascular hypertensive rats.
Li P; Huang PP; Yang Y; Liu C; Lu Y; Wang F; Sun W; Kong XQ
J Appl Physiol (1985); 2017 Jan; 122(1):121-129. PubMed ID: 27742806
[TBL] [Abstract][Full Text] [Related]
13. Aldosterone Contributes to Sympathoexcitation in Renovascular Hypertension.
Lincevicius GS; Shimoura CG; Nishi EE; Perry JC; Casarini DE; Gomes GN; Bergamaschi CT; Campos RR
Am J Hypertens; 2015 Sep; 28(9):1083-90. PubMed ID: 25628418
[TBL] [Abstract][Full Text] [Related]
14. New insights into the renoprotective actions of the renin inhibitor aliskiren in experimental renal disease.
Feldman DL
Hypertens Res; 2010 Apr; 33(4):279-87. PubMed ID: 20203685
[TBL] [Abstract][Full Text] [Related]
15. Naringenin Ameliorates Renovascular Hypertensive Renal Damage by Normalizing the Balance of Renin-Angiotensin System Components in Rats.
Wang Z; Wang S; Zhao J; Yu C; Hu Y; Tu Y; Yang Z; Zheng J; Wang Y; Gao Y
Int J Med Sci; 2019; 16(5):644-653. PubMed ID: 31217731
[No Abstract] [Full Text] [Related]
16. Contrasting effects of aliskiren versus losartan on hypertensive vascular remodeling.
Martins-Oliveira A; Castro MM; Oliveira DM; Rizzi E; Ceron CS; Guimaraes D; Reis RI; Costa-Neto CM; Casarini DE; Ribeiro AA; Gerlach RF; Tanus-Santos JE
Int J Cardiol; 2013 Aug; 167(4):1199-205. PubMed ID: 22483258
[TBL] [Abstract][Full Text] [Related]
17. The Role of RAAS Inhibition by Aliskiren on Paracetamol-Induced Hepatotoxicity Model in Rats.
Karcioglu SS; Palabiyik SS; Bayir Y; Karakus E; Mercantepe T; Halici Z; Albayrak A
J Cell Biochem; 2016 Mar; 117(3):638-46. PubMed ID: 26280784
[TBL] [Abstract][Full Text] [Related]
18. Aliskiren: renin inhibitor for hypertension management.
Cheng JW
Clin Ther; 2008 Jan; 30(1):31-47. PubMed ID: 18343241
[TBL] [Abstract][Full Text] [Related]
19. Direct inhibition of renin as a cardiovascular pharmacotherapy: focus on aliskiren.
Sepehrdad R; Frishman WH; Stier CT; Sica DA
Cardiol Rev; 2007; 15(5):242-56. PubMed ID: 17700383
[TBL] [Abstract][Full Text] [Related]
20. Renin inhibition reverses renal disease in transgenic mice by shifting the balance between profibrotic and antifibrotic agents.
Kavvadas P; Weis L; Abed AB; Feldman DL; Dussaule JC; Chatziantoniou C
Hypertension; 2013 Apr; 61(4):901-7. PubMed ID: 23438929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
